Jaime Hudson’s Post

When it comes to #bioprocess media, the company I always recommend is RoosterBio Inc. Their RoosterNourish™ is the industry's best-performing bioprocess media used for MSC expansion from R&D through clinical manufacturing. Years of formula and process optimization have increased productivity and eliminated media exchanges, which can drastically reduce your costs and expansion time by up to 60%. DID YOU KNOW that RoosterNourish media provides the same benefits to multiple cell types? •  Fibroblasts •  Immortalized MSCs • iPSC-derived MSCs • Autologous MSCs Learn more here: https://lnkd.in/gjnvQpmG #msc #stemcells #research #cellculture Kim Hastings

As I look back on my last few months with the exceptional team at Cube Biotech, a true powerhouse in drug discovery. I am reminded of the importance of our work. Our recent research has produced numerous new potential targets in drug discovery, reinforcing our position as a critical player in the field. 60% of FDA-approved drugs target membrane proteins. Thirty percent of the human genome codes for membrane proteins, but only two percent has been structurally determined. Today, we extensively use detergents to develop drug structures, assays, and screenings. Much progress has been made with detergents, but despite massive time and money investment, there are still so many potential targets between the GPCR, ion channels, and ABC transporters that remain unsolved. Perhaps one of the keys is that lipids are essential for membrane protein function. Over 100,000 research papers describe protein-lipid interactions. Using membrane protein solubilization with copolymers preserves the native host cell's lipid environment and function. For the first time, with the Native MP platform, we can perform assays at body temperature with full-length wild-type GPCRs that can be analyzed! Our work is not just technical jargon but a testament to our ability to provide new tools that could lead to many years of life-saving drugs and significantly improve patient care. This potential impact on patient care underscores the importance of our research and keeps us motivated in our pursuit of the production of new potential targets.

When it comes to #bioprocess media, the company we always recommend is RoosterBio Inc. Their RoosterNourish™ is the industry's best-performing bioprocess media used for MSC expansion from R&D through clinical manufacturing. Years of formula and process optimization have increased productivity and eliminated media exchanges, which can drastically reduce your costs and expansion time by up to 60%. DID YOU KNOW that RoosterNourish media provides the same benefits to multiple cell types? •  Fibroblasts •  Immortalized MSCs • iPSC-derived MSCs • Autologous MSCs Learn more here: https://lnkd.in/eEE4BTuP #msc #stemcells #research #cellculture

Flashback from last month.. Networking is truly an Art !! Going to tradeshows ranging from Biopharma, Medicine, Plant & Animal biology and Molecular research surely teaches one the value of personal relationships, broadening horizons with ideas from such a diverse pool of minds. The challenges of expanding into a new market definitely rewards one with opportunities to interact with the best minds and keep growing! #BusinessExpansion #Marketing #TechnicalSales #Networking

One of the #lifescience sector's most important voices in understanding the economic value of #patientcentricity - Jen Horonjeff - “Ask Patients”! Whenever we connect, I feel the #biopharma industry can realize its greater potential. Here at Scope Summit #SCOPEsummit.

It was a thrill to ride today with Iman Daryaei, Ph.D., Martin Fuchs, Peter Nestler, and Marco Schito from TheraCea Pharma, Metfora, Biodarix Lifesciences LLC, and Critical Path Institute (C-Path) and of course UGenome AI. #ugenome, #ugenomeai, #pharmacogenomics, #pharmacogenetics, #bioinformatics, #genetics, #dna, #research, #genomics, #medicine, #drugdiscovery, #datascience, #biostatistics, #pharma, #genomicmedicine, #sequencing, #dataanalysis, #precisionmedicine

Interesting clip (and a link to a full length webinar) on #MedPharm's 3D nasal cast model! #nasaldelivery #nasalformulationdevelopment

Another useful #human_curated platform for #medicinal_chemists or #chemical_biologists. Earlier we were developed an approach for target/ligand discovery which I named it #evidence_based_drug_discovery in which we are extracting the needed data from different resources which #CAS_Biofinder integrated and now it’s easier for us to extract our data. One of the main aspects of #evidence_based_drug_discovery is data from #clinical_trials and I think by integrating databases like #chembl, #CAS_Biofinder, #kegg and other sources this approach will be more applicable.

𝗗𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀? 𝗪𝗲'𝘃𝗲 𝗴𝗼𝘁 𝘆𝗼𝘂𝗿 𝗯𝗮𝗰𝗸! If you are attending #SwissBiotechDay in Basel, we're available at booth #75, ready to hear about your projects and your needs. Our team is here to help you overcome roadblocks and optimize your path to successful drug development with protein crystallography. Stop by and let's chat! #SwissBiotechDay #Innovation #DrugDiscovery #StructuralBiology

We are excited to share that our portfolio company Aeovian Pharmaceuticals has closed a $50 million follow-on round. This marks an important milestone as we commenced clinical trials in our quest to extend healthy human lifespan. The round was led by Hevolution Foundation’s William Greene and supported by existing investors venBio, Sofinnova Investments , Evotec, and Apollo Health Ventures. Originating from the Buck Institute for Research on Aging, Aeovian is pioneering the development of rapamycin analog compounds. Rapamycin is famous for its ability to target the fundamentals of aging and age-related diseases and works even very well in aged animals. Human application is currently limited by its side effects. Aeovian’s 'rapalogs' are designed to mitigate the limitations of traditional rapamycin by allowing higher dosages without the associated toxicity. Analog compounds of rapamycin rank among the most promising drugs to change the paradigm in treating age-related diseases. If you're interested in learning more about the progress aging science has already made, read our article on Medium: https://lnkd.in/esnizjKE #ApolloVC #Healthspan #Lifespan #LifescienceVC #VentureCapital